DNA treatment could delay paralysis that strikes nearly all patients with ALS

In virtually all persons with amyotrophic lateral sclerosis (ALS) and in up to half of all cases of Alzheimer’s disease (AD) and frontotemporal dementia, a protein called TDP-43 is lost from its normal location in the nucleus of the cell. In turn, this triggers the loss of stathmin-2, a protein crucial to regeneration of neurons and the maintenance of their connections to muscle fibers, essential to contraction and movement.

Writing in the March 16, 2023 issue of Science, a team of scientists, led by senior study author Don Cleveland, PhD, Distinguished Professor of Medicine, Neurosciences and Cellular and Molecular Medicine at University of California San Diego School of Medicine, with colleagues and elsewhere, demonstrate that stathmin-2 loss can be rescued using designer DNA drugs that restore normal processing of protein-encoding RNA.

“With mouse models we engineered to misprocess their stathmin-2 encoding RNAs, like in these human diseases, we show that administration of one of these designer DNA drugs into the fluid that surrounds the brain and spinal cord restores normal stathmin-2 levels throughout the nervous system,” Cleveland said.

Cleveland is broadly credited with developing the concept of designer DNA drugs, which act to either turn on or turn off genes associated with many degenerative diseases of the aging human nervous system, including ALS, AD, Huntington’s disease and cancer.

Several designer DNA drugs are currently in clinical trials for multiple diseases. One such drug has been approved to treat a childhood neurodegenerative disease called spinal muscular atrophy.

The new study builds upon ongoing research by Cleveland and others regarding the role and loss of TDP-43, a protein associated with ALS, AD and other neurodegenerative disorders. In ALS, TDP-43 loss impacts the motor neurons that innervate and trigger contraction of skeletal muscles, causing them to degenerate, eventually resulting in paralysis.

“In almost all of instances of ALS, there is aggregation of TDP-43, a protein that functions in maturation of the RNA intermediates that encode many proteins. Reduced TDP-43 activity causes misassembly of the RNA-encoding stathmin-2, a protein required for maintenance of the connection of motor neurons to muscle,” said Cleveland.

“Without stathmin-2, motor neurons disconnect from muscle, driving paralysis that is characteristic of ALS. What we have now found is that we can mimic TDP-43 function with a designer DNA drug, thereby restoring correct stathmin-2 RNA and protein level in the mammalian nervous system.”

Specifically, the researchers edited genes in mice to contain human STMN2 gene sequences and then injected antisense oligonucleotides — small bits of DNA or RNA that can bind to specific RNA molecules, blocking their ability to make a protein or changing how their final RNAs are assembled — into cerebral spinal fluid. The injections corrected STMN2 pre-mRNA misprocessing and restored stathmin-2 protein expression fully independent of TDP-43 function.

“Our findings lay the foundation for a clinical trial to delay paralysis in ALS by maintaining stathmin-2 protein levels in patients using our designer DNA drug,” Cleveland said.

Co-authors include: Michael W. Baughn, Jone López-Erauskin, Melinda S. Beccari, Roy Maimon, Sonia Vazquez-Sanchez, Jonathan W. Artates and Eitan Acks, all at Ludwig Institute for Cancer Research-UC San Diego and UC San Diego; Ze’ev Melamed, Ludwig Institute for Cancer Research-UC San Diego, UC San Diego, and The Hebrew University of Jerusalem; Karen Ling, Paayman Jafar-nejad, Frank Rigo and C. Frank Bennett, all at Ionis Pharmaceuticals; Aamir Zuberi, Maximilliano Presa, Elena Gonzalo-Gil and Cathleen Lutz, all at The Jackson Laboratory; Som Chaturvedi, Mariana Bravo-Hernández, Vanessa Taupin and Stephen Moore, all at UC San Diego; L. Sandra Ndayambaje and Ana R. Agra de Almeida Quadros, Harvard Medical School; Clotilde Lagier-Tourenne, Harvard University and Broad Institute of Harvard University and Massachusetts Institute of Technology.

Share Button

Breast cancer gene linked to Orkney islands

A gene variant known to increase the risk of breast cancer has been found in people with Orkney heritage.

Share Button

Missed contraceptive coil left woman unable to have children

Jayne Huddleston believed her contraceptive coil had fallen out after a GP failed to spot it.

Share Button

Researchers chart a course for understanding, preventing, and treating young-onset colorectal cancer

Colorectal cancer among young people is increasing globally and rapidly. Experts expect it to become the leading cause of cancer death in individuals aged 20-49 in the U.S. by the year 2030.

Yet no one is certain why this disease is suddenly affecting so many young people. In a new paper published in Science, Dana-Farber Cancer Institute researchers outline the complexities of the disease and the research needed to map out a path toward understanding it.

“The rising incidence of young-onset colorectal cancer is extremely concerning, and it is urgent that the scientific community comes together to better understand the underlying causes and biology,” said co-author Kimmie Ng, MD, MPH, associate chief of gastrointestinal oncology and director of the Young-Onset Colorectal Cancer Center at Dana-Farber. The Center provides expert care for patients and conducts the multidisciplinary research required to understand colorectal cancer in young adults and develop new ways to prevent, detect and treat it.

Young-onset Colorectal Cancer: a unique challenge

Young-onset colorectal cancer (CRC), also called early-onset CRC, differs from later-onset CRC in several ways, according to the authors. Young-onset disease is often more aggressive, presents on the left side of the colon rather than the right, and often presents with rectal bleeding and abdominal pain.

At a molecular level, however, studies have shown conflicting results that suggest both similarities and differences in the genetic mutations that drive the diseases. This is likely due to the complexity of the disease, according to the authors, and future research should account for this variability.

More study is also needed to determine if CRC risk factors for young people are similar to those for older adults. Obesity and environmental exposures, for instance, have been associated with young-onset disease, but other factors could also play a role, such as increased antibiotic use or the frequency of Cesarean sections, both of which could influence the microbiome. To begin to understand the risk factors, the authors suggest that investigations should include a combination of genetics, environmental exposures, diet and lifestyle measures, as well as immune system interactions and the microbiome composition.

One clear difference is that young-onset CRC is typically discovered after the disease has advanced. This is due in part to the fact that screening for colorectal cancer starts at age 45 in the U.S., so the disease often goes undetected in younger people.

“It’s important not to dismiss the idea that a young person could have colorectal cancer even though the disease is still more common in older adults,” said co-author Marios Giannakis, MD, PhD, a gastrointestinal oncologist at Dana-Farber.

Responding with multidisciplinary research involving diverse populations

To account for the complexity of young-onset CRC, Ng and Giannakis said that research should be multidisciplinary and include many areas of investigation simultaneously. For instance, genome-wide association studies, which aim to find risk genes for the disease, should also include data about environmental exposures that could also increase risk.

These types of studies could point to new ways to identify young people who are at high risk of young-onset disease and should be screened for CRC. “Risk stratification is going to be very important as we think about screening for young-onset disease,” said Giannakis.

Clinical studies should also include the collection of blood, tissue, and stool samples from patients over time to shed light on the role of immune cells, environmental exposures and the microbiome in disease onset, progression, and treatment response. Ng and Giannakis encourage global collaborations aimed at facilitating the collection of these specimens, such as the Count Me In Colorectal Cancer Project, which directly partners with patients in the U.S. and Canada and makes all data available for research.

Ng and Giannakis also call for more effort in ensuring diverse populations are included in studies of young-onset CRC. Studies show underrepresented minorities are disproportionally burdened by young-onset CRC and non-Hispanic Black patients have a higher mortality rate when compared to non-Hispanic whites.

“Although each of these steps require commitment and perseverance,” said the authors, “it is the growing numbers of young patients bravely battling this disease that will be the compass that keeps us on the path towards better understanding, preventing, and treating young-onset colorectal cancer.”

Share Button

Tinder’s New Data Shows People Are Tired Of Messing Around On Apps

Nobody likes uncertainty, especially when you’re dating someone. Dating apps are a pain to navigate as it is, so you really don’t want people to be wasting your time on it when your intentions don’t align.

But there are so many people who simply do not make their intentions clear from the get go, and then we’re all in for a merry-go-round ride we never asked to get on. Then come the situationships, the one sided attachments and the inevitable heartbreaks.

And with dating apps making it easy to have so many options, people often forget to consider how painful it can for others when you’re not clear about what you want.

And you know what? People are finally tired of it. Because a new research from Tinder has revealed that 73% of singles are now only looking to date someone who is clear about what they want.

The data also revealed that 52% of Gen Z prefers monogamous relationships, while 41% of them are open to or are actively seeking non monogamous or open relationships.

In light of this, Tinder is adding a relationship type feature onto its app so people can make their intentions clear from the get go.

Tinder already has a relationship goals feature where people can let everyone know what their dating intentions are, and it could be quite helpful for people who just do not want their time wasted by things that they don’t want. Bumble and Hinge have this feature too.

However this new feature will help make it clear what type of relationship they want.

Using the relationship type feature, people on Tinder can specify whether they want a monogamous, ethically non monogamous, open, or polyamorous relationship. They can also say that they are open to exploring things.

“The term ‘commitment’ is not one-size-fits-all for this new generation. They’re exploring a range of possibilities — from monogamy to situationships to friendship — and it’s really important for them to be open and transparent about what they’re looking for. We’re making it easy for them to do this with features like Relationship Types and Relationship Goals,” said Kyle Miller, VP of Product at Tinder.

Making your intentions clear from the very beginning can make it easy to avoid any future headaches and unnecessary heartbreaks. Dating is also incredibly time consuming, and spending all those hours and cash on someone who isn’t even on the same page as you is a luxury not many people can afford.

So it honestly comes as no surprise that people are done with uncertainty. No one likes to be toyed with, especially when it comes to their emotions.

People are fed up with the games. So if you’re someone who is doing that, now might be a good time to stop. Or you can fuck around and find out. Your call.

Share Button

Grant Shapps Delivers A Blunt Message To The Government After TikTok Ban

Grant Shapps has delivered a blunt message to the government after it introduced a TikTok ban.

Oliver Dowden, the Chancellor of the Duchy of Lancaster, announced that the app would be removed from all government devices amid cybersecurity fears.

But Shapps, who is energy secretary, made it clear on his own TikTok account that he would not be closing down his own account.

He posted a 45-second clip on TikTok from the hit moving The Wolf of Wall Street, in which Leonardo DiCaprio tells a cheering crowd “I’m not fucking leaving.”

DiCaprio’s character, Jordan Belfort, adds: “The show goes on. This is my home. They’re gonna need a wrecking ball to take me out of here.”

Shapps added: “This morning the government announced a TikTok ban on government devices. That’s sensible.

“I’ve never used TikTok on government devices and can hereby confirm I will NOT be leaving TikTok any time soon.”

His post is a stinging rebuke to Dowden, who had earlier said: “Restricting the use of TikTok on Government devices is a prudent and proportionate step following advice from our cyber security experts.”

TikTok requires users to give permission for the app to access data stored on the device, which is then collected and stored by the company.

That gives TikTok access to a range of data on the device, including contacts, user content, and geolocation data.

Ministers are believed to be concerned about the way in which this data may be used by TikTok’s owners, the Chinese company ByteDance.

Parliament’s TikTok account was shut down last year after MPs raised concerns over the firm’s links to China.

The US government banned TikTok last year on federal government-issued devices due to national security concerns.

Meanwhile, staff working at the European Commission have been ordered to remove the TikTok app from their phones and corporate devices.

A TikTok spokesperson said: “We are disappointed with this decision. We believe these bans have been based on fundamental misconceptions and driven by wider geopolitics, in which TikTok, and our millions of users in the UK, play no part.

“We remain committed to working with the government to address any concerns but should be judged on facts and treated equally to our competitors.

“We have begun implementing a comprehensive plan to further protect our European user data, which includes storing UK user data in our European data centres and tightening data access controls, including third-party independent oversight of our approach.”

Share Button

George Ezra 2023 tour: Vertigo diagnosis shines light on symptom

George Ezra’s cancelled tour dates after being diagnosed with it – so we spoke to others with it.

Share Button

Unions close to pay deal with government to avert more NHS strikes

An agreement on health workers’ pay could be announced as early as Thursday afternoon.

Share Button

Linfield footballer Ross Larkin ‘lucky to be alive’ after cancer

Northern Ireland under-21 defender Ross Larkin had a brain tumour just before Christmas 2021.

Share Button

Doctors’ strike fallout could take weeks to resolve, NHS bosses say

Tens of thousands are likely to have been affected by a walkout in England, which ends on Thursday morning.

Share Button